Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

NCT00430027 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped This study was terminated due slow accrual.

Conditions

Esophageal Adenocarcinoma

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Cetuximab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]